Cargando…
S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428421/ http://dx.doi.org/10.1097/01.HS9.0000968132.86513.06 |
| _version_ | 1785090465115144192 |
|---|---|
| author | Scully, Marie Baptista, Jovanna Bhattacharya, Indranil Cataland, Spero Coppo, Paul Cuccia, Loredana Dutt, Tina Susan Huang, Shih-Han Pascual Izquierdo, Cristina Eva Mingot-Castellano, María Parnes, Aric Pavenski, Katerina Rajavel, Kavitha Jarque, Isidro Wang, Linda T. Fernández Zarzoso, Miguel Zhu, Andy Mellgård, Björn |
| author_facet | Scully, Marie Baptista, Jovanna Bhattacharya, Indranil Cataland, Spero Coppo, Paul Cuccia, Loredana Dutt, Tina Susan Huang, Shih-Han Pascual Izquierdo, Cristina Eva Mingot-Castellano, María Parnes, Aric Pavenski, Katerina Rajavel, Kavitha Jarque, Isidro Wang, Linda T. Fernández Zarzoso, Miguel Zhu, Andy Mellgård, Björn |
| author_sort | Scully, Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428421 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284212023-08-17 S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA Scully, Marie Baptista, Jovanna Bhattacharya, Indranil Cataland, Spero Coppo, Paul Cuccia, Loredana Dutt, Tina Susan Huang, Shih-Han Pascual Izquierdo, Cristina Eva Mingot-Castellano, María Parnes, Aric Pavenski, Katerina Rajavel, Kavitha Jarque, Isidro Wang, Linda T. Fernández Zarzoso, Miguel Zhu, Andy Mellgård, Björn Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428421/ http://dx.doi.org/10.1097/01.HS9.0000968132.86513.06 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Scully, Marie Baptista, Jovanna Bhattacharya, Indranil Cataland, Spero Coppo, Paul Cuccia, Loredana Dutt, Tina Susan Huang, Shih-Han Pascual Izquierdo, Cristina Eva Mingot-Castellano, María Parnes, Aric Pavenski, Katerina Rajavel, Kavitha Jarque, Isidro Wang, Linda T. Fernández Zarzoso, Miguel Zhu, Andy Mellgård, Björn S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA |
| title | S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA |
| title_full | S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA |
| title_fullStr | S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA |
| title_full_unstemmed | S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA |
| title_short | S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA |
| title_sort | s305: phase 2 randomized, placebo-controlled, double-blind, multicenter study of recombinant adamts13 in patients with immune-mediated thrombotic thrombocytopenic purpura |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428421/ http://dx.doi.org/10.1097/01.HS9.0000968132.86513.06 |
| work_keys_str_mv | AT scullymarie s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT baptistajovanna s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT bhattacharyaindranil s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT catalandspero s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT coppopaul s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT cuccialoredana s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT dutttina s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT susanhuangshihhan s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT pascualizquierdocristina s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT evamingotcastellanomaria s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT parnesaric s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT pavenskikaterina s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT rajavelkavitha s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT jarqueisidro s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT wanglindat s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT fernandezzarzosomiguel s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT zhuandy s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura AT mellgardbjorn s305phase2randomizedplacebocontrolleddoubleblindmulticenterstudyofrecombinantadamts13inpatientswithimmunemediatedthromboticthrombocytopenicpurpura |